Literature DB >> 2808482

Effect of steroid hormones on human colorectal adenocarcinoma xenografts, of known steroid-receptor status, in nude mice.

W S Stebbings1, G P Vinson, M J Farthing, F Balkwill, R F Wood.   

Abstract

The effect of hormone therapy on the growth of human colonic adenocarcinoma xenografts in nude mice was evaluated. Primary xeno-transplantation for ten different human colorectal adenocarcinomas into nude mice yielded a tumour take of 50%. One of these host tumours was found to contain androgen receptors (8 fmol/mg cytosol protein; Kd 0.73 x 10(-9) M), which were maintained in the xenograft at the third and ninth passages, but not expressed at the tenth and twelfth passages. The host tumour and its xenograft did not express either oestrogen or progesterone receptors. Administration of dihydrotestosterone led to inhibition of xenograft growth at the ninth passage compared with untreated controls (P less than 0.05), but had no effect on xenograft growth at the tenth and twelfth passages when androgen receptors were absent. Stilboestrol and progesterone failed to influence xenograft growth. In conclusion, dihydrotestosterone administration led to inhibition of xenograft growth only in the presence of androgen receptor, suggesting that some colorectal cancers might be considered steroid-hormone-sensitive tumours.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2808482     DOI: 10.1007/bf00393333

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  14 in total

1.  The nude mouse vs. the hypothesis of immunological surveillance.

Authors:  J Rygaard; C O Povlsen
Journal:  Transplant Rev       Date:  1976

2.  Cancer of the colon and rectum and adenomatous polyps. A review of epidemiologic findings.

Authors:  W Haenszel; P Correa
Journal:  Cancer       Date:  1971-07       Impact factor: 6.860

Review 3.  Do intrinsic sex differences in lower alimentary tract physiology influence the sex-specific risks of bowel cancer and other biliary and intestinal diseases?

Authors:  A J McMichael; J D Potter
Journal:  Am J Epidemiol       Date:  1983-11       Impact factor: 4.897

4.  The control of human pancreatic adenocarcinoma xenografts in nude mice by hormone therapy.

Authors:  B Greenway; D Duke; B Pym; M J Iqbal; P J Johnson; R Williams
Journal:  Br J Surg       Date:  1982-10       Impact factor: 6.939

5.  Studies in an animal model on the effectiveness of adjuvant chemotherapy with 5-FU and BCNU in cases of colorectal adenocarcinoma.

Authors:  R Schmitz; J Hüper; R Pichlmayr
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

6.  Steroid hormone receptors in human colon cancers.

Authors:  T C Alford; H M Do; G W Geelhoed; N T Tsangaris; M E Lippman
Journal:  Cancer       Date:  1979-03       Impact factor: 6.860

7.  A hybrid ligand method for androgen receptor measurement.

Authors:  W S Stebbings; E Anderson; J R Puddefoot; M J Farthing; G P Vinson
Journal:  J Steroid Biochem       Date:  1988-08       Impact factor: 4.292

8.  Effects of steroid hormone therapy on primarily xenotransplanted human colorectal adenocarcinomas.

Authors:  J R Izbicki; R Schmitz; H O Hoppen; W Izbicki; H Troidl
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

9.  Steroid receptors and the distribution of IR-carcinoembryonic antigen in colonic cancer.

Authors:  E Odagiri; K Jibiki; R Demura; H Shinozaki; S Nakamura; H Demura; H Suzuki
Journal:  Dis Colon Rectum       Date:  1984-12       Impact factor: 4.585

10.  Androgen receptors in experimentally induced colon carcinogenesis.

Authors:  J R Izbicki; G Wambach; S R Hamilton; E Harnisch; R Hogenschurz; W Izbicki; J Kusche
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

View more
  6 in total

1.  Sex hormones and colorectal cancer: what have we learned so far?

Authors:  Jennifer H Lin; Edward Giovannucci
Journal:  J Natl Cancer Inst       Date:  2010-11-10       Impact factor: 13.506

2.  Risk of colorectal cancer in men on long-term androgen deprivation therapy for prostate cancer.

Authors:  Silke Gillessen; Arnoud Templeton; Giancarlo Marra; Yong-Fang Kuo; Emanuele Valtorta; Vahakn B Shahinian
Journal:  J Natl Cancer Inst       Date:  2010-11-10       Impact factor: 13.506

Review 3.  Oestrogen and colorectal cancer: mechanisms and controversies.

Authors:  Paul A Foster
Journal:  Int J Colorectal Dis       Date:  2013-01-15       Impact factor: 2.571

4.  Concordant colon tumors in monozygotic twins previously treated for prostate cancer.

Authors:  Arnoud Templeton; Giancarlo Marra; Emanuele Valtorta; Karl Heinimann; Hansjakob Müller; Dieter Köberle; Silke Gillessen
Journal:  Fam Cancer       Date:  2008-11-16       Impact factor: 2.375

5.  Possible contribution of beta-glycosidases and caspases in the cytotoxicity of novel glycoconjugates in colon cancer cells.

Authors:  Hossam M M Arafa
Journal:  Invest New Drugs       Date:  2009-05-05       Impact factor: 3.850

6.  Spatial expression of IKK-alpha is associated with a differential mutational landscape and survival in primary colorectal cancer.

Authors:  Meera Patel; Kathryn A F Pennel; Jean A Quinn; Hannah Hood; David K Chang; Andrew V Biankin; Selma Rebus; Antonia K Roseweir; James H Park; Paul G Horgan; Donald C McMillan; Joanne Edwards
Journal:  Br J Cancer       Date:  2022-02-16       Impact factor: 9.075

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.